|
Quotes & Info
|
| USU > SEC Filings for USU > Form 10-Q on 7-May-2009 | All Recent SEC Filings |
7-May-2009
Quarterly Report
• are deploying what we anticipate will be the world's most advanced uranium enrichment technology, known as the American Centrifuge,
• are the exclusive executive agent for the U.S. government under a nuclear nonproliferation program with Russia, known as Megatons to Megawatts,
• perform contract work for the U.S. Department of Energy ("DOE") and its contractors at the Paducah and Portsmouth gaseous diffusion plants ("GDPs"), and
• provide transportation and storage systems for spent nuclear fuel and provide nuclear and energy consulting services.
Low Enriched Uranium
LEU consists of two components: separative work units ("SWU") and uranium.
SWU is a standard unit of measurement that represents the effort required to
transform a given amount of natural uranium into two components: enriched
uranium having a higher percentage of U235 and depleted uranium having a lower
percentage of U235. The SWU contained in LEU is calculated using an industry
standard formula based on the physics of enrichment. The amount of enrichment
deemed to be contained in LEU under this formula is commonly referred to as the
SWU component and the quantity of natural uranium used in the production of LEU
under this formula is referred to as its uranium component.
We produce or acquire LEU from two principal sources. We produce LEU at the
Paducah GDP in Paducah, Kentucky. Under the Megatons to Megawatts program, we
acquire LEU from Russia under a contract, which we refer to as the Russian
Contract, to purchase the SWU component of LEU recovered from dismantled nuclear
weapons from the former Soviet Union for use as fuel in commercial nuclear power
plants.
Our View of the Business Today
The long-term outlook for the nuclear industry continues to strengthen as
environmental concerns about climate change and volatility in the price of
fossil fuels have encouraged utilities to increase the generation of nuclear
power. There are approximately 440 nuclear power reactors worldwide in operation
today, and international agencies report that more than 100 reactors are on
order or planned to be built over the next two decades. U.S. utilities have
filed 17 applications for construction and operating licenses for 26 new
reactors with the U.S. Nuclear Regulatory Commission ("NRC").
To fuel potential new reactors, uranium enrichment capacity will need to
double by 2030, according to the World Nuclear Association. New uranium
enrichment plants, including our American Centrifuge Plant and other competing
projects in the United States and worldwide, are being proposed and built to
meet this new demand and to replace remaining higher production cost gaseous
diffusion plants.
We believe the growth in potential demand for nuclear fuel over the next two
decades provides a strong foundation for our substantial investment in the
American Centrifuge Plant ("ACP"). Nonetheless, we face significant challenges
in 2009 as we seek additional financing needed to continue the ACP, and over the
next several years as we transition our sources of LEU supply.
Even as we build our new production facility, we have substantial current
operations at the gaseous diffusion plant we lease from the U.S. government in
Paducah, Kentucky. Today, we produce about half of our supply of low enriched
uranium at the Paducah GDP and purchase half from Russia under a highly
successful, nonproliferation program known as "Megatons to Megawatts." Over the
next several years we expect to transition the source of our LEU supply to
production from the ACP.
Our Paducah plant requires a large amount of electric power, and prices for
electricity and related fuel have been very volatile during the past year.
During non-summer months of 2009, we expect to purchase 2,000 megawatts of power
from TVA. We have a fixed-price contract that sets the base price for most of
the power we purchase, but our costs fluctuate above or below the base contract
price based on fuel and purchased power costs experienced by TVA. In 2008, this
fuel cost adjustment increased our power cost over the base contract price by
about 15%, which had a significant effect on our net income and cash flow from
operations. The impact of current economic conditions on energy prices has
lowered recent weekly power invoices compared to 2008 and market prices for
electric power for the summer of 2009 are lower than last summer. Volatility in
power prices and TVA's cost of fuel continue, which results in uncertainty in
our financial projections.
American Centrifuge Plant Update
We have been developing and demonstrating a highly efficient uranium
enrichment gas centrifuge technology that we call the American Centrifuge. We
are deploying this technology in the American Centrifuge Plant being built in
Piketon, Ohio. Since August 2007 we have operated a cascade of prototype
machines in our Lead Cascade test program that has provided valuable data on
operational characteristics of the machine, aided in developing improvements to
the design of the commercial production machines and given staff operational
experience.
We refer to our production centrifuge machine design as the AC100 series
centrifuge machine. The AC100 series machine is designed to produce 350 SWU per
year, which output is substantially greater than our competitors' machines.
Within this overall AC100 design, we have finalized two design releases. The
first was released to our strategic suppliers in 2008 in preparation for
installing a test cascade of these AC100 series machines in Piketon in 2009. In
late March 2009, we completed a second design release for the AC100 series
machines, which we refer to as the AC100 Mod 1 machine. We are continuing to
value engineer the centrifuge design to reduce the cost of manufacturing the
machine and simplify subsystems, which will result in future versions of the
AC100 series.
The American Centrifuge uranium enrichment technology has demonstrated
performance above our current target of 350 SWU per machine, per year. Our plan
is to seek sustained improvement in centrifuge design that will be integrated
into the commercial plant over time. Before a new version of the machine is
introduced into the ACP, a design review board will determine through a
disciplined process if the improvements provide sufficient cost and performance
improvement to implement.
At our state-of-the-art test facilities in Oak Ridge, Tennessee we have been
testing individual centrifuge machines with improved operating characteristics
and a lower cost to manufacture. We intend to integrate these improvements in
future versions of the AC100. We have several test stands operating now with
AC100 centrifuges. We believe these facilities provide the environment for
testing future, improved versions of the machine.
Our strategic suppliers have been manufacturing parts for the initial AC100
machines since 2008. In manufacturing parts for the AC100, suppliers must
replicate on a commercial basis manufacturing that we previously self-performed
in building our prototype machines. We are working with leading companies to
create a world-class industrial infrastructure needed to build components for
the AC100 machines and supporting equipment. The specialized U.S. manufacturing
base needed to build the AC100 did not exist but is being established with our
leadership. Under contract arrangements with USEC, our suppliers are also
helping to create the manufacturing base for a revitalized U.S. nuclear fuel
industry in a dozen states.
A cascade of initial AC100 machines is expected to be operational early in
the third quarter of 2009. This cascade will be in a closed-loop configuration
as required under our demonstration license from the NRC but will otherwise
operate under commercial plant conditions. During this continuation of our Lead
Cascade testing program we expect to obtain data on machine-to-machine
interactions, plant design, subsystem performance, various support systems such
as the service module, and cascade electronic control systems. Many of the
initial machines for this cascade have been assembled, are operating and are
being conditioned with uranium hexafluoride gas in preparation for cascade
operations. Additional machines will be added during the summer until we reach
40 to 50 AC100 machines in Lead Cascade testing. These 40 to 50 machines are
expected to operate into 2010.
We expect the first machines in the initial AC100 series cascade will have a
throughput somewhat less than 350 SWU per year as we continue to optimize the
AC100 series machine. However, we remain confident that the AC100 series
machines that are deployed in the commercial plant will achieve an average
performance level of 350 SWU per year, supporting an annual SWU production
capacity of the ACP of 3.8 million SWU.
During the first quarter of 2009, we announced that we began taking steps to
conserve cash and reduce the planned escalation of project construction and
machine manufacturing activities until we gain greater certainty on potential
funding for the project through the DOE Loan Guarantee Program. However, we
continue to invest as planned in engineering design, machine value engineering
and the initial AC100 series cascade deployment.
The reduction in the planned escalation principally affected construction of
the plant's interior infrastructure that had been expected to ramp up
significantly in 2009. Construction of the ACP includes various systems
including electric, telecommunications, cooling, and water distribution.
Although plant construction has slowed to conserve cash, we have continued with
engineering and design for the commercial plant by Fluor Corporation. The design
is approximately 75% complete. The two existing production buildings have space
for approximately 11,500 centrifuges. The availability of machine mounts that
anchor the centrifuges in place is complete in one production building and about
90% complete in the second building. Work continues on the total refurbishment
of the feed and withdrawal facility, and installation of the piping between this
facility and the production buildings is expected to begin in the third quarter.
Other activities include refurbishing the machine assembly area, constructing a
new boiler building and related equipment, and building a monorail system in the
machine assembly building during the second half of 2009.
Our decision to slow spending until a decision is made by the DOE Loan
Guarantee Program will increase costs and extend the schedule for the completion
of the project. We are currently engaged with our strategic suppliers in
assessing the potential impact on cost and schedule and the potential impact
will depend on the length and severity of our spending slowdown. We expect to
provide an update as we gain greater certainty on potential funding through the
DOE Loan Guarantee Program.
Our Marketing and Sales department continues to meet with customers to sell
ACP output, which is important to our financing efforts for ACP. Sales contracts
for this initial output represent a strategic commitment by customers to ensure
a reliable, U.S.-based source of nuclear fuel that will be available for decades
to come. Leading nuclear utilities in the United States, Europe and Asia have
committed to purchase a substantial portion of the plant's output through both
accepted offers and signed contracts for terms of varying lengths extending as
far as 2026. At the end of the first quarter of 2009, we announced that we have
commitments from 10 customers to purchase more than half of the planned, initial
sales of the ACP. These commitments are valued at $3.3 billion.
We continue to anticipate a potential expansion of the ACP beyond the initial
3.8 million SWU plant, which could be done incrementally once the initial ACP
construction phase is complete. The manufacturing infrastructure that we are
putting into place to deploy the initial plant capacity will facilitate any
future expansion. Because an expansion would not require creating this
manufacturing infrastructure or another demonstration of the technology, the
cost of any expansion is anticipated to be less than the initial project.
Revenue from Sales of SWU and Uranium
Revenue from our LEU segment is derived primarily from:
• sales of the SWU component of LEU,
• sales of both the SWU and uranium components of LEU, and
• sales of uranium.
The majority of our customers are domestic and international utilities that
operate nuclear power plants, with international sales constituting
approximately 30% of revenue from our LEU segment in 2008. Our agreements with
electric utilities are primarily long-term, fixed-commitment contracts under
which our customers are obligated to purchase a specified quantity of SWU from
us or long-term requirements contracts under which our customers are obligated
to purchase a percentage of their SWU requirements from us. Under requirements
contracts, a customer only makes purchases when its reactor has requirements.
The timing of requirements is associated with reactor refueling outages. Our
agreements for uranium sales are generally shorter-term, fixed-commitment
contracts.
Our revenues and operating results can fluctuate significantly from quarter
to quarter, and in some cases, year to year. Customer demand is affected by,
among other things, reactor operations, maintenance and the timing of refueling
outages. Utilities typically schedule the shutdown of their reactors for
refueling to coincide with the low electricity demand periods of spring and
fall. Thus, some reactors are scheduled for annual or two-year refuelings in the
spring or fall, or for 18-month cycles alternating between both seasons.
Customer payments for the SWU component of LEU typically average approximately
$15 million per order. As a result, a relatively small change in the timing of
customer orders for LEU due to a change in a customer's refueling schedule may
cause operating results to be substantially above or below expectations.
Customer requirements and orders are more predictable over the longer term, and
we believe our performance is best measured on an annual, or even longer,
business cycle. Our revenue could be adversely affected by actions of the NRC or
nuclear regulators in foreign countries issuing orders to modify, delay, suspend
or shut down nuclear reactor operations within their jurisdictions.
Our financial performance over time can be significantly affected by changes in prices for SWU and uranium. The long-term SWU price indicator, as published by TradeTech, LLC in Nuclear Market Review, is an indication of base-year prices under new long-term enrichment contracts in our primary markets. Since our backlog includes contracts awarded to us in previous years, the average SWU price billed to customers typically lags behind the current price indicators. Following are the long-term SWU price indicator, the long-term price for uranium hexafluoride ("UF6"), as calculated using indicators published in Nuclear Market Review, and the spot price indicator for UF6:
March 31, December 31, March 31,
2009 2008 2008
Long-term SWU price indicator ($/SWU) $ 161.00 $ 159.00 $ 145.00
UF6:
Long-term price composite ($/KgU) 192.54 195.15 260.47
Spot price indicator ($/KgU) 121.00 140.00 195.00
|
A substantial portion of our earnings and cash flows in recent years has been
derived from sales of uranium, including uranium generated by underfeeding the
production process at the Paducah GDP. We may also purchase uranium from
suppliers in connection with specific customer contracts, as we have in the
past. Underfeeding is a mode of operation that uses or feeds less uranium but
requires more SWU in the enrichment process, which requires more electric power.
In producing the same amount of LEU, we vary our production process to underfeed
uranium based on the economics of the cost of electric power relative to the
prices of uranium and enrichment. Spot market prices for uranium declined in the
past year while electric power costs generally increased, pressuring the
economics of underfeeding the enrichment process to obtain uranium for resale.
Given supply and demand conditions in the spot uranium market, we see fewer
opportunities for near-term spot sales. We will continue to monitor and optimize
the economics of our production based on the cost of power and market conditions
for SWU and uranium.
We supply uranium to the Russian Federation for the LEU we receive under the
Russian Contract. We replenish our uranium inventory with uranium supplied by
customers under our contracts for the sale of SWU and through underfeeding our
production process. Our older contracts give customers the flexibility to
determine the amounts of natural uranium that they deliver to us, which can
result in our receiving less uranium from customers than we transfer from our
inventory to the Russian Federation under the Russian Contract. Our new SWU
sales contracts and certain older contracts that we have renegotiated require
customers to deliver a greater amount of natural uranium to us.
Under the terms of many uranium sale agreements, title to uranium is
transferred to the customer and we receive payment under normal credit terms
without physically delivering the uranium to the customer. The recognition of
revenue and earnings for such uranium sales is deferred until LEU associated
with such uranium is physically delivered to the customer rather than at the
time title to uranium transfers to the customer. The timing of revenue
recognition for uranium sales is uncertain.
Revenue from U.S. Government Contracts
We perform and earn revenue from contract work for DOE and DOE contractors at
the Paducah and Portsmouth GDPs, including a contract for maintenance of the
Portsmouth GDP in cold shutdown. DOE and USEC have periodically extended the
Portsmouth GDP cold shutdown contract, most recently through June 30, 2009. DOE
has announced its intention to negotiate a sole-source extension of the cold
shutdown contract through September 30, 2010. Continuation of U.S. government
contracts is subject to DOE funding and Congressional appropriations. Revenue
from U.S. government contracts is based on allowable costs determined under
government cost accounting standards. Allowable costs include direct costs as
well as allocations of indirect plant and corporate overhead costs and are
subject to audit by the Defense Contract Audit Agency. Also refer to "DOE
Contract Services Matter" in note 10 to the consolidated condensed financial
statements. Revenue from the U.S. government contracts segment includes revenue
from our subsidiary NAC International Inc. ("NAC").
Cost of Sales
Cost of sales for SWU and uranium is based on the amount of SWU and uranium
sold and delivered during the period and is determined by a combination of
inventory levels and costs, production costs, and purchase costs. Production
costs consist principally of electric power, labor and benefits, long-term
depleted uranium disposition cost estimates, materials, depreciation and
amortization, and maintenance and repairs. The quantity of uranium that is added
to uranium inventory from underfeeding is accounted for as a byproduct of the
enrichment process. Production costs are allocated to the uranium added to
inventory based on the net realizable value of the uranium, and the remainder of
production costs is allocated to SWU inventory costs. Under the monthly moving
average inventory cost method that we use, coupled with our inventories of SWU
and uranium, an increase or decrease in production or purchase costs will have
an effect on inventory costs and cost of sales over current and future periods.
We have agreed to purchase approximately 5.5 million SWU each calendar year
for the remaining term of the Russian Contract through 2013. Purchases under the
Russian Contract are approximately one-half of our supply mix. Prices are
determined using a discount from an index of international and U.S. price
points, including both long-term and spot prices. A multi-year retrospective
view of the index is used to minimize the disruptive effect of short-term market
price swings. Increases in these price points in recent years have resulted in
increases to the index used to determine prices under the Russian Contract.
There were no deliveries under the Russian Contract in the three months ended
March 31, 2009. In April 2009, deliveries resumed after the Russian government
approved the price for 2009. The purchase cost per SWU for 2009 is expected to
be 11% higher compared to 2008.
The pricing methodology under the Russian Contract for deliveries in 2010
through 2013 was amended in February 2009. The U.S. government has approved the
amendment and approval by the Russian government is pending. The new pricing
methodology is intended to enhance the stability of future pricing for both
parties through a formula that combines a different mix of price points and
other pricing elements. We expect that prices paid under the Russian Contract,
as amended, will continue to increase year over year, and that the total amount
paid to the Russian Federation for the SWU component of the LEU delivered under
the Russian Contract over the 20 year term of the contract will substantially
exceed $8 billion by the time the contract is completed in 2013. Officials of
the Russian government have announced that Russia will not extend the Russian
Contract or the government-to-government agreement it implements, beyond 2013.
Accordingly, we do not anticipate that we will purchase Russian SWU after 2013.
We provide for the remainder of our supply mix from the Paducah GDP. The
gaseous diffusion process uses significant amounts of electric power to enrich
uranium. Costs for electric power are approximately 70-75% of production costs
at the Paducah GDP. We purchase most of the electric power for the Paducah GDP
under a power purchase agreement with TVA that expires May 31, 2012. The base
price under the TVA power contract increases moderately based on a fixed, annual
schedule, and is subject to a fuel cost adjustment provision to reflect changes
in TVA's fuel costs, purchased power costs, and related costs. The impact of the
fuel cost adjustment has been negative for USEC, imposing an average increase
over base contract prices of about 15% in 2008 and 8% in 2007. The impact of
future fuel cost adjustments, which is substantially influenced by coal prices
and hydroelectric power availability, is uncertain and our cost of power could
fluctuate in the future above or below the agreed increases in the base energy
price. We expect the fuel cost adjustment to continue to cause our purchase cost
to remain above base contract prices, but the impact is uncertain given volatile
energy prices.
Advanced Technology Costs
Costs relating to the American Centrifuge technology are charged to expense
or capitalized based on the nature of the activities and estimates and judgments
involving the completion of project milestones. Costs relating to the
demonstration of American Centrifuge technology are charged to expense as
incurred. Demonstration costs historically have included NRC licensing of the
American Centrifuge Demonstration Facility in Piketon, Ohio, engineering
activities, and assembling and testing of centrifuge machines and equipment at
centrifuge test facilities located in Oak Ridge, Tennessee and at the American
Centrifuge Demonstration Facility.
Capitalized costs relating to the American Centrifuge technology include NRC
licensing of the American Centrifuge Plant in Piketon, Ohio, engineering
activities, construction of centrifuge machines and equipment, leasehold
improvements and other costs directly associated with the commercial plant.
Capitalized centrifuge costs are recorded in property, plant and equipment as
part of construction work in progress. The continued capitalization of such
costs is subject to ongoing review and successful project completion. During the
second half of 2007, we moved from a demonstration phase to a commercial plant
phase in which significant expenditures are capitalized based on management's
judgment that the technology has a high probability of commercial success and
meets internal targets related to physical control, technical achievement and
economic viability. If conditions change and deployment were no longer probable,
costs that were previously capitalized would be charged to expense.
Expenditures related to American Centrifuge technology for the three months
ended March 31, 2009 and 2008, as well as cumulative expenditures as of
March 31, 2009, follow (in millions):
Cumulative
Three Months Ended as of
March 31, March 31,
2009 2008 2009
Amount expensed as part of advanced technology
costs $ 31.4 $ 23.5 $ 573.5
Amount capitalized as part of property, plant and
equipment (A) 130.2 110.3 774.5
Prepayments to suppliers for services not yet
performed 0.1 4.7 24.8
Total ACP expenditures, including accruals (B) $ 161.7 $ 138.5 $ 1,372.8
|
(A) Cumulative
capitalized
costs as of
March 31, 2009
include
interest of
$30.7 million.
(B) Total
expenditures
are all
American
Centrifuge
costs
including, but
not limited
to,
demonstration
facility,
licensing
activities,
commercial
plant
facility,
program
management,
interest
related costs
and accrued
asset
retirement
obligations
capitalized.
This includes
$43.5 million
of accruals at
March 31,
2009.
For discussions of the financing plan for the American Centrifuge project,
see "Management's Discussion and Analysis - Liquidity and Capital Resources."
Risks and uncertainties related to the financing, construction and deployment of
the American Centrifuge Plant are described in Item 1A, "Risk Factors" of our
2008 Annual Report on Form 10-K.
Advanced technology costs also include research and development efforts
. . .
|
|